These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30684342)

  • 21. [Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?].
    Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1807-12. PubMed ID: 12215924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
    AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single nucleotide polymorphisms of toll-like receptor 7 and toll-like receptor 9 in hepatitis C virus infection patients from central China.
    Wei XS; Wei CD; Tong YQ; Zhu CL; Zhang PA
    Yonsei Med J; 2014 Mar; 55(2):428-34. PubMed ID: 24532514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stronger hepatitis C virus-specific CD8+ T-cell responses in HIV coinfection.
    Barrett L; Gallant M; Howley C; Ian Bowmer M; Hirsch G; Peltekian K; Grant M
    J Viral Hepat; 2011 Mar; 18(3):170-80. PubMed ID: 20497309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.
    Thong VD; Akkarathamrongsin S; Avihingsanon A; Theamboonlers A; Poovorawan Y; Tangkijvanich P
    Intervirology; 2015; 58(2):73-9. PubMed ID: 25677196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
    Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
    BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management and treatment of chronic hepatitis C in HIV patients.
    Barreiro P; Vispo E; Labarga P; Soriano V
    Semin Liver Dis; 2012 May; 32(2):138-46. PubMed ID: 22760653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.
    Behzadpour D; Ahmadi Vasmehjani A; Mousavi Nasab SD; Ahmadi NA; Baharlou R
    Pathog Glob Health; 2016; 110(7-8):310-315. PubMed ID: 27830997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection.
    Schott E; Witt H; Neumann K; Taube S; Oh DY; Schreier E; Vierich S; Puhl G; Bergk A; Halangk J; Weich V; Wiedenmann B; Berg T
    J Hepatol; 2007 Aug; 47(2):203-11. PubMed ID: 17512627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV-HCV coinfected patients, irrespective of liver disease severity.
    Feuth T; Van Baarle D; Hoepelman AI; Van Erpecum KJ; Siersema PD; Arends JE
    Apoptosis; 2014 Jul; 19(7):1128-35. PubMed ID: 24752774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relating the outcome of HCV infection and different host SNP polymorphisms in a Majorcan population coinfected with HCV-HIV and treated with pegIFN-RBV.
    Matas M; Picornell A; Cifuentes C; Payeras A; Homar F; González-Candelas F; López-Labrador FX; Moya A; Ramon C; Castro JA
    Int Microbiol; 2014 Mar; 17(1):11-20. PubMed ID: 25296442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients.
    Parra M; Laufer N; Manrique JM; Jones LR; Quarleri J
    Biomed Res Int; 2017; 2017():1728456. PubMed ID: 29259976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of the associations between HIV/HCV coinfection and biomarkers of cardiovascular disease.
    Osibogun O; Ogunmoroti O; Michos ED; Spatz ES; Olubajo B; Nasir K; Maziak W
    Rev Med Virol; 2018 Jan; 28(1):. PubMed ID: 29135056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endosomal toll-like receptor gene polymorphisms and susceptibility to HIV and HCV co-infection - Differential influence in individuals with distinct ethnic background.
    Valverde-Villegas JM; Dos Santos BP; de Medeiros RM; Mattevi VS; Lazzaretti RK; Sprinz E; Kuhmmer R; Chies JA
    Hum Immunol; 2017 Feb; 78(2):221-226. PubMed ID: 28062211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
    Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil.
    Le Marchand C; Bahia F; Page K; Brites C
    Braz J Infect Dis; 2015; 19(5):486-91. PubMed ID: 26254690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.
    Neukam K; Morano-Amado LE; Rivero-Juárez A; Mancebo M; Granados R; Téllez F; Collado A; Ríos MJ; de Los Santos-Gil I; Reus-Bañuls S; Vera-Méndez F; Geijo-Martínez P; Montero-Alonso M; Suárez-Santamaría M; Pineda JA
    HIV Clin Trials; 2017 May; 18(3):126-134. PubMed ID: 28599618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus.
    Yu JW; Sun LJ; Zhao YH; Kang P; Gao J; Li SC
    Liver Int; 2009 Nov; 29(10):1485-93. PubMed ID: 19602134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.